The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liquid and tissue profiling of somatic mutational landscape of non-small cell lung cancer from an Indian cohort.
 
Sewanti Atul Limaye
Employment - Sir H N Reliance Foundation Hospital and Research Centre
Leadership - Iylon; Sir H N Reliance Foundation Hospital and Research Centre
Stock and Other Ownership Interests - Iylon
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
 
Umut Disel
No Relationships to Disclose
 
Nick Plowman
Employment - Amethyst Radiotherapy Group BV; HCA Healthcare; The London Clinic
Stock and Other Ownership Interests - Datar Cancer Genetics
Consulting or Advisory Role - Amethyst Radiotherapy Group BV; HCA Healthcare; The London Clinic
 
Nitesh Rohatgi
Honoraria - Guardant Health AMEA; Lilly; Roche India
Consulting or Advisory Role - Guardant Health AMEA
 
Nelofer Syed
No Relationships to Disclose
 
Datar Limited
Employment - Datar Cancer Genetics
Leadership - Datar Cancer Genetics
Stock and Other Ownership Interests - Datar Cancer Genetics
 
Vineet Datta
Employment - Datar Cancer Genetics
Leadership - Datar Cancer Genetics
Stock and Other Ownership Interests - Datar Cancer Genetics
 
Darshana Patil
Employment - Datar Cancer Genetics
Leadership - Datar Cancer Genetics
Stock and Other Ownership Interests - Datar Cancer Genetics
 
Nirmal Vivek Raut
No Relationships to Disclose
 
Dr T Raja
Speakers' Bureau - AstraZeneca; Merck; Novartis; Pfizer; Roche India; Zydus Pharmaceuticals
 
Razelle Kurzrock
Leadership - CureMatch; CureMetrix
Stock and Other Ownership Interests - CureMatch; CureMetrix; IDbyDNA
Honoraria - AACR; Bicara Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; Foundation Medicine; LEK; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Roche; Turning Point Therapeutics; Wiley
Consulting or Advisory Role - Actuate Therapeutics; AstraZeneca; Bicara Therapeutics; Biological Dynamics; Caris Life Sciences; Daiichi Sankyo; Datar Genomics; Eisai; EOM Pharmaceuticals; Gaido; Iylon; Loxo; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Prosperdtx; Regeneron; Roche; Soluventis; TD2/Volastra; Turning Point Therapeutics; XBiotech
Speakers' Bureau - NeoGenomics Laboratories; Roche
Research Funding - Biological Dynamics (Inst); Boehringer Ingelheim (Inst); Debiopharm Group (Inst); Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); MedImmune (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst); Takeda (Inst); Top Alliance BioScience (Inst)
Travel, Accommodations, Expenses - NCI SWOG; TargetCancer Foundation